Why the study?
Does the Prostar vascular closure device reduce vascular complications and device failures compared to two ProGlide devices in patients undergoing transfemoral TAVI?
Does the Prostar vascular closure device reduce vascular complications and device failures compared to two ProGlide devices in patients undergoing transfemoral TAVI?
Answers are grounded in this paper and cite their sources.
The use of the Prostar vascular closure device may be associated with fewer vascular complications and device failures compared to using two ProGlide devices during transfemoral TAVI.
Patients undergoing transfemoral TAVI had significantly lower rates of vascular complications and percutaneous closure device failures when the Prostar was used compared with two ProGlide devices.
No takes yet. Share an insight, caveat, or question.
Barbanti et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: